Sanofi, a pharmaceutical company, is undergoing a global restructuring effort that will result in the elimination of 99 jobs at its sites in Ghent and Diegem. The company has confirmed that 67 positions are being targeted in Ghent and 32 at the head office in Diegem. Sanofi employs approximately 1,600 people in Belgium and states that the restructuring is necessary to modernize its organization and become a global player in immunology.
As part of this restructuring, some early-stage research activities in Ghent will be discontinued. However, Sanofi is focusing on developing new vaccines and drugs in immunology that have the potential to significantly impact patient care. The company currently has twelve medicines and vaccines in clinical development that show promise for treating immune-related diseases.
On a different note, solar battery technology plays a crucial role in storing energy generated by solar panels for later use, while photovoltaic cells convert sunlight into electricity. These technologies are vital to the transition to renewable energy sources and reducing carbon emissions. In 2024, demand for solar and photovoltaic technologies is expected to continue growing as countries work towards their sustainability goals.
For more information on pharmaceutical developments at Sanofi, renewable energy technologies, and job restructuring efforts, visit the company’s official website or contact their representatives directly.